The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.

Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pfizer has earned a nod from the U.S. regulator for another of its products in the indication. On Friday, the FDA signed ...

Not only that, the drug didn ... The FDA has already approved more than a dozen antipsychotics for schizophrenia, and many have inexpensive generic versions that patients may be encouraged to try ...

The US Food and Drug Administration (FDA) has approved inavolisib (Itovebi, Genentech) in combination with palbociclib and fulvestrant for endocrine-resistant, PIK3CA-mutated, hormone receptor ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US. The FDA has approved Imuldosa (ustekinumab ... 10 medications selected by ...

AP: Bimbo Bakeries Pushes Back On FDA Sesame Allergy Warning A top U.S. commercial bakery is pushing back on a Food and Drug Administration warning to ... are “misbranded” because the labels list ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

In a lawsuit in Fort Worth, Texas federal court, the Outsourcing Facilities Association claims the FDA removed Lilly’s tirzepatide from the list even though it remains in short supply. Lilly sells the ...

Mounjaro had been on the FDA’s list of drugs in short supply since late 2022, while Zepbound was added in April. Compounding facilities create medicines by combining, mixing or altering drug ...

The United States Food and Drug Administration (FDA) has recently approved a plant-based gel designed to rapidly stop bleeding and enhance the body’s natural clotting process. “The ability to rapidly ...